Profile picture of Jeremy Khong

Dr Jeremy Khong

Profile picture of Jeremy Khong

MBBS, FRANZCR

Radiation Oncologist
Call
Enquire
Referrals

Dr Jeremy Khong is committed to a holistic, patient-centred approach to care, ensuring each patient’s needs, values, and concerns are understood and respected with empathy. He values delivering personalised, evidence-based treatments aimed at achieving optimal clinical outcomes, patient satisfaction, and enhanced quality of survivorship.

Biography

Dr Jeremy Khong is a highly skilled Radiation Oncologist at Icon Cancer Centre Noarlunga and Warrnambool. He completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at the University of Adelaide in 2015 and became a Fellow of the Royal Australian and New Zealand College of Radiologists (FRANZCR) in 2023. Dr Khong has trained extensively across Australia and the United Kingdom, including a Clinical Fellowship in Proton Beam Therapy at The Christie NHS Foundation Trust.

Dr Khong has a strong commitment to research, having authored multiple peer-reviewed publications in radiation oncology, including studies on cochlear sparing techniques and radiotherapy for skin cancers. He is currently the Principal Investigator for a clinical trial exploring Epstein-Barr Virus (EBV) DNA clearance during proton beam therapy for nasopharyngeal carcinoma. Dr Khong is also an Honorary Research Fellow at The Christie NHS Foundation Trust and a Clinical Associate Lecturer at the University of Adelaide.

In addition to his clinical expertise, Dr Khong is deeply involved in clinical research and consumer engagement. He has presented at international conferences such as the Paediatric Radiation Oncology Society Congress and hosted workshops with patients and the public to better understand their unmet needs. Through his combination of clinical acumen, research innovation, and educational contributions, Dr Khong remains dedicated to delivering world-class cancer care and advancing the field of radiation oncology.

Publications

  • Khong, J., Abou-Hamden, A., Koszyca, B., Roos, D., & Govindaraj, R. (2024). Long-term control of haemorrhagic brain metastases from atrial myxoma after radiotherapy. British journal of neurosurgery, 1–6. Advance online publication. https://doi.org/10.1080/02688697.2024.2395373

    Khong, J., Tee, H., Gorayski, P., Le, H., Penniment, M., Jessop, S., Hansford, J., Penfold, M., Green, J., Skelton, K., & Saran, F. (2023). Proton beam therapy in paediatric cancer: Anticipating the opening of the Australian Bragg Centre for Proton Therapy and Research. Journal of medical imaging and radiation oncology, 10.1111/1754-9485.13614. Advance online publication. https://doi.org/10.1111/1754-9485.13614

    Khong, J., Govindaraj, R., Ramm, D., Edwards, S., & Roos, D. (2023). Cochlear sparing in LINAC-based radiosurgery for vestibular schwannoma: a dosimetric comparison of dynamic conformal arc, IMRT and VMAT treatment plans. Radiation oncology (London, England)18(1), 2. https://doi.org/10.1186/s13014-022-02188-y

    Govindaraj, R., Khong, J., Byrne, A., Zacest, A., & Roos, D. (2022). The Effect of Cochlear Dose on Hearing Preservation After Low-Dose Stereotactic Radiosurgery for Vestibular Schwannomas: A Systematic Review. Advances in radiation oncology7(6), 101059. https://doi.org/10.1016/j.adro.2022.101059.

    Khong, J., Gorayski, P., & Roos, D. (2020). Non-melanoma skin cancer in general practice: Radiotherapy is an effective treatment option. Australian journal of general practice49(8), 496–499. https://doi.org/10.31128/AJGP-10-19-5130

Special Interests

Dr Jeremy Khong accepts referrals for all cancer types, with a special clinical interest in:

  • Breast cancer
  • Gastrointestinal cancer
  • Lung cancer
  • Palliative radiotherapy
  • Skin cancer
  • Urological cancer

Languages spoken

  • English

Affiliations & Memberships

  • Australian Health Practitioner Regulation Agency (AHPRA)
  • Brain Tumour Research SA (BTRSA)
  • General Medical Council (GMC, UK)
  • European Society for Radiotherapy and Oncology (ESTRO)
  • Trans-Tasman Radiation Oncology Group (TROG)

Publications

  • Khong, J., Abou-Hamden, A., Koszyca, B., Roos, D., & Govindaraj, R. (2024). Long-term control of haemorrhagic brain metastases from atrial myxoma after radiotherapy. British journal of neurosurgery, 1–6. Advance online publication. https://doi.org/10.1080/02688697.2024.2395373

    Khong, J., Tee, H., Gorayski, P., Le, H., Penniment, M., Jessop, S., Hansford, J., Penfold, M., Green, J., Skelton, K., & Saran, F. (2023). Proton beam therapy in paediatric cancer: Anticipating the opening of the Australian Bragg Centre for Proton Therapy and Research. Journal of medical imaging and radiation oncology, 10.1111/1754-9485.13614. Advance online publication. https://doi.org/10.1111/1754-9485.13614

    Khong, J., Govindaraj, R., Ramm, D., Edwards, S., & Roos, D. (2023). Cochlear sparing in LINAC-based radiosurgery for vestibular schwannoma: a dosimetric comparison of dynamic conformal arc, IMRT and VMAT treatment plans. Radiation oncology (London, England)18(1), 2. https://doi.org/10.1186/s13014-022-02188-y

    Govindaraj, R., Khong, J., Byrne, A., Zacest, A., & Roos, D. (2022). The Effect of Cochlear Dose on Hearing Preservation After Low-Dose Stereotactic Radiosurgery for Vestibular Schwannomas: A Systematic Review. Advances in radiation oncology7(6), 101059. https://doi.org/10.1016/j.adro.2022.101059.

    Khong, J., Gorayski, P., & Roos, D. (2020). Non-melanoma skin cancer in general practice: Radiotherapy is an effective treatment option. Australian journal of general practice49(8), 496–499. https://doi.org/10.31128/AJGP-10-19-5130

Search

Contact us
Become a patient